SMAIO SA (ALSMA.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ALSMA - FR0014005I80 - Common Stock
ALSMA.PA Key Statistics, Chart & Performance
The current stock price of ALSMA.PA is 6.65 EUR. In the past month the price increased by 0.76%. In the past year, price increased by 186.64%.
ALSMA.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.78 | 117.07B | ||
| 1MDT.MI | MEDTRONIC PLC | 18.64 | 114.29B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.88 | 48.21B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.41 | 23.39B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.41 | 23.38B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.67 | 23.11B | ||
| BIM.PA | BIOMERIEUX | 28.2 | 12.88B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 155 | 4.66B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 26.25 | 4.01B | ||
| DIA.MI | DIASORIN SPA | 18.56 | 3.44B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.93 | 1.32B | ||
| DRW8.DE | DRAEGERWERK AG | 9.86 | 1.19B |
Related stock screener links
About ALSMA.PA
Company Profile
S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes and currently employs 41 full-time employees. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software.
Company Info
SMAIO SA
2 Place Berthe Morisot, Parc Technologique
Saint-Priest AUVERGNE-RHONE-ALPES FR
Employees: 41
Phone: 33469842302
SMAIO SA / ALSMA.PA FAQ
What does ALSMA do?
S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes and currently employs 41 full-time employees. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software.
What is the stock price of SMAIO SA today?
The current stock price of ALSMA.PA is 6.65 EUR. The price increased by 0.76% in the last trading session.
Does SMAIO SA pay dividends?
ALSMA.PA does not pay a dividend.
What is the ChartMill rating of SMAIO SA stock?
ALSMA.PA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is SMAIO SA worth?
SMAIO SA (ALSMA.PA) has a market capitalization of 37.57M EUR. This makes ALSMA.PA a Nano Cap stock.
ALSMA.PA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ALSMA.PA. When comparing the yearly performance of all stocks, ALSMA.PA is one of the better performing stocks in the market, outperforming 98.51% of all stocks.
ALSMA.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ALSMA.PA. The financial health of ALSMA.PA is average, but there are quite some concerns on its profitability.
ALSMA.PA Financial Highlights
Over the last trailing twelve months ALSMA.PA reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 36.05% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.39% | ||
| ROE | -25% | ||
| Debt/Equity | 0.33 |
ALSMA.PA Forecast & Estimates
10 analysts have analysed ALSMA.PA and the average price target is 8.26 EUR. This implies a price increase of 24.24% is expected in the next year compared to the current price of 6.65.
For the next year, analysts expect an EPS growth of 48.75% and a revenue growth 81.82% for ALSMA.PA